Information about PVpharm
El martes 24-10-2023 tuvo lugar en el Rectorado de la Universidad, la firma Aula de Farmacovigilancia UGR & PVPharm, un espacio dedicado a incrementar el conocimiento y aprendizaje sobre Farmacovigilancia y la Industria Farmacéutica. Al acto de firma acudieron entre otros el Sr. Rector Magnífico de la Universidad, D. Pedro Mercado Pacheco, el CEO y fundador de PVPharm, D. José Alberto Ayala Ortiz, y el Sr. Decano de la Facultad,. D. Manuel Sánchez Polo. https://youtu.be/oJh6yrA3l5M El objetivo general de la presente colaboración entre PVpharm y la UGR es apoyar la realización de actividades de formación y difusión en el ámbito de la…
Noche de los Investigadores 2023, PVpharm
The European Researchers' Night is a Europe-wide public event, which displays the diversity of science and its impact on citizens' daily lives in fun, inspiring ways. This year, the event will take place in 26 countries on Friday 29 September 2022. The European Researchers' Night aims to: -bring research and researchers closer to the public-promote excellent research projects across Europe and beyond-increase the interest of young people in science and research careers-showcase the impact of researchers’ work on people’s daily lives The European Researchers’ Night attracts each year more than 1 million visitors in Europe and beyond. Researcher's Night 2023…
PVpharm has enjoyed several sessions where the team has enjoyed sailing on one of the most wonderful landscapes of Spain, the coast of Almeria.
We are very glad to announce that José Alberto Ayala Ortiz has been selected as one of the top ten CEOs of 2023. Industry Tech Outlook has chosen José, a full article has been issued at the magazine website, it can be found here: https://industry-techoutlook.com/magazine/Top-10-CEOs-Of-2023/ Being the CEO of PVpharm, José is a visionary and inspirational leader. He sets a clear direction for the organization's future while motivating and uniting the organization. José’s leadership drives growth, innovation, and success, creating a positive work environment, attracting top talent, and building solid stakeholder relationships. The company has been growing in business since…
PVpharm is going to participate in the next events of the pharmaceutical and biotechnology industry in Spain. Farmaforum will be held in Madrid from September 19 to 20, and BIOSPAIN will be held in Barcelona from September 26 to 28. Come visit us and let's talk about pharmacovigilance services, safety in clinical trials, audits, quality and many other topics related to drug development. We are looking forward to seeing you!
PVpharm led the way in pharmacovigilance training by innovatively organizing another edition of its Pharmacovigilance Training. This 3rd edition was hosted on May, 2022.
On 12-15 June 2023, José Ortiz provided the training faculty for the Signal Management training organized by DIA. This training provides knowledge over Signal Management to the participants, so they can apply the basic concepts and principles of signal detection in pharmacovigilance, from simple visualisation and tabulation methods to sophisticated data mining techniques. • Design the signal management process for institutions and companies of various sizes, portfolios and geographical presence, based on the possibilities and limitations of their data and resources • Understand key messages from the current European and US regulations on signal management, to best manage implications also…
We are happy to announce that José Alberto Ayala Ortiz, PVpharm's CEO will be participating in one session of the 2023 Pharmacovigilance symposium organized by AEFI. During the session, José will be talking about safety in food or food supplements. Please take a look to the program at this link: https://www.aefi2023.com/
We are so excited to announce the new collaboration agreement signed by our company with the International AIDS Vaccine Initiative (IAVI) to provide pharmacovigilance and regulatory consulting. IAVI is a nonprofit scientific research organization that develops vaccines and antibodies for HIV, tuberculosis, emerging infectious diseases (including COVID-19), and other neglected diseases, with a clear commitment to develop affordable and accesible solutions to these diseases. In the same way as our collaboration with the Leiden University Medical Center (LUMC) or with the Center for Human Drug Research (CHDR), PVpharm works to provide pharmacovigilance support in pre-approval phases of the development of innovative drugs. In this agreement, we…
PVpharm is in "El Economista" on 9th May 2023, the news diary published an article about PVpharm; where our CEO, José Alberto Ayala Ortiz, introduces our company, explains what pharmacovigilance is and how does PVpharm deal with different regulations. PVpharm is a global reference in Pharmacovigilance: https://www.eleconomista.es/branded-content/noticias/12258631/05/23/jose-alberto-ayala-ortiz-pvpharm-somos-una-referencia-global-en-el-campo-de-la-farmacovigilancia.html You can follow us on LinkedIn and learn more about us clicking here.
